Effects of gender affirming hormone treatment in transgender individuals - a retrospective cohort study.
Christopher A MuirMihal Guttman-JonesElspeth J ManPublished in: Endocrine (2024)
Most TGD patients achieve target testosterone levels within 9 months of GAHT initiation. Adverse effects of GAHT are rare, and are usually mild.